Evidence map›Paper›PMID 38780707›Full record

Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2024

Telehealth cognitive behaviour therapy for the management of sleep disturbance in women with early breast cancer receiving chemotherapy: a feasibility study.

Emma-Kate Carson, Haryana M Dhillon, Janette L Vardy, Chris Brown, Kelly Ferrao Nunes-Zlotkowski, Stephen Della-Fiorentina, Sarah Khan, Andrew Parsonson, Felicia Roncoloato, Antonia Pearson and 2 more

Abstract readMulticenter StudyClinical Trial, Phase II
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Emma-Kate CarsonFaculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia. emmakate.carson@health.nsw.gov.au.ORCID http://orcid.org/0000-0001-9684-0247
Haryana M DhillonCentre for Medical Psychology & Evidence-Based Decision-Making, University of Sydney, Sydney, NSW, Australia.
Janette L VardyFaculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
Chris BrownFaculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
Kelly Ferrao Nunes-ZlotkowskiCentre for Medical Psychology & Evidence-Based Decision-Making, University of Sydney, Sydney, NSW, Australia.
Stephen Della-FiorentinaSchool of Medicine, Western Sydney University, Campbelltown, NSW, Australia.
Sarah KhanSouthern Highlands Cancer Centre, Southern Highlands Private Hospital, Bowral, NSW, Australia.
Andrew ParsonsonMacarthur Cancer Therapy Centre, Campbelltown Hospital, Campbelltown, NSW, Australia.
Felicia RoncoloatoFaculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
Antonia PearsonFaculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.
Tristan BarnesFaculty of Medicine, Health and Human Sciences, Macquarie University, Macquarie Park, NSW, Australia.
Belinda E KielyFaculty of Medicine and Health, University of Sydney, Camperdown, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSleep quality commonly deteriorates in people receiving chemotherapy for breast cancer (BC). We aimed to determine feasibility and acceptability of telehealth-delivered cognitive behaviour therapy for insomnia (CBT-I) in people with early BC receiving (neo)adjuvant chemotherapy.

methodsMulti-centre, single arm, phase 2 feasibility trial. People with stage I-III BC received 4 sessions of telehealth CBT-I over 8 weeks, during chemotherapy. Participants completed Pittsburgh Sleep Quality Index (PSQI) and other Patient Reported Outcome Measures (PROMs) at baseline, post-program (week 9) and post-chemotherapy (week 24); and an Acceptability Questionnaire at week 9. Primary endpoint was proportion completing 4 sessions of telehealth CBT-I.

resultsIn total, 41 participants were recruited: mean age 51 years (range 31-73). All 4 CBT-I sessions were completed by 35 (85%) participants. Acceptability of the program was high and 71% reported 'the program was useful'. There was no significant difference in the number of poor sleepers (PSQI score ≥ 5) at baseline 29/40 (73%) and week 24 17/25 (68%); or in the mean PSQI score at baseline (7.43, SD 4.06) and week 24 (7.48, SD 4.41). From baseline to week 24, 7/25 (28%) participants had a ≥ 3 point improvement in sleep quality on PSQI, and 5/25 (20%) had a ≥ 3 point deterioration. There was no significant difference in mean PROM scores.

conclusionIt is feasible to deliver telehealth CBT-I to people with early BC receiving chemotherapy. Contrary to literature predictions, sleep quality did not deteriorate. Telehealth CBT-I has a potential role in preventing and managing sleep disturbance during chemotherapy. Australian New Zealand Clinical Trials Registry (ANZCTR) registration number: ACTRN12620001379909 and date 22/12/2020.

Indexed as

Breast NeoplasmsCognitive Behavioral TherapyFeasibility StudiesTelemedicineAdultAgedFemaleHumansMiddle AgedPatient Reported Outcome MeasuresSleep Initiation and Maintenance DisordersSleep QualitySleep Wake DisordersSurveys and QuestionnairesBreast cancerChemotherapyInsomniaQuality of lifeSleep disturbanceTelehealth

Identifiers

PMID38780707
PMCPMC11116244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.